Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

The ischemic penumbra: identification, evolution and treatment concepts.

Fisher M.

Cerebrovasc Dis. 2004;17 Suppl 1:1-6. Review.

PMID:
14694275
2.

The ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke. The Johann Jacob Wepfer award 2011.

Heiss WD.

Cerebrovasc Dis. 2011;32(4):307-20. doi: 10.1159/000330462. Epub 2011 Sep 15. Review.

3.

The penumbra, therapeutic time window and acute ischaemic stroke.

Fisher M, Takano K.

Baillieres Clin Neurol. 1995 Aug;4(2):279-95. Review.

PMID:
7496621
4.

Understanding and managing ischemic stroke.

Barber PA, Auer RN, Buchan AM, Sutherland GR.

Can J Physiol Pharmacol. 2001 Mar;79(3):283-96. Review.

PMID:
11294605
5.

The ischemic penumbra: a new opportunity for neuroprotection.

Fisher M.

Cerebrovasc Dis. 2006;21 Suppl 2:64-70. Epub 2006 May 2.

PMID:
16651816
6.

Evolving paradigms for neuroprotection: molecular identification of ischemic penumbra.

Castellanos M, Sobrino T, Castillo J.

Cerebrovasc Dis. 2006;21 Suppl 2:71-9. Epub 2006 May 2. Review.

PMID:
16651817
7.

The concept of ischemic penumbra in acute stroke and therapeutic opportunities.

Paciaroni M, Caso V, Agnelli G.

Eur Neurol. 2009;61(6):321-30. doi: 10.1159/000210544. Epub 2009 Apr 9. Review.

8.

The role of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke: from laboratory to clinics.

Tatlisumak T, Strbian D, Abo Ramadan U, Li F.

Curr Vasc Pharmacol. 2004 Oct;2(4):343-55. Review.

PMID:
15320814
9.

Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke.

Liu R, Yuan H, Yuan F, Yang SH.

Neurol Res. 2012 May;34(4):331-7. doi: 10.1179/1743132812Y.0000000020. Review.

PMID:
22643076
10.

Oxygen therapy in acute ischemic stroke - experimental efficacy and molecular mechanisms.

Poli S, Veltkamp R.

Curr Mol Med. 2009 Mar;9(2):227-41. Review.

PMID:
19275631
11.

SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.

Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.

Exp Neurol. 2008 Jul;212(1):53-62. doi: 10.1016/j.expneurol.2008.03.011. Epub 2008 Mar 25.

PMID:
18462720
12.

Inhalation of nitric oxide prevents ischemic brain damage in experimental stroke by selective dilatation of collateral arterioles.

Terpolilli NA, Kim SW, Thal SC, Kataoka H, Zeisig V, Nitzsche B, Klaesner B, Zhu C, Schwarzmaier S, Meissner L, Mamrak U, Engel DC, Drzezga A, Patel RP, Blomgren K, Barthel H, Boltze J, Kuebler WM, Plesnila N.

Circ Res. 2012 Mar 2;110(5):727-38. doi: 10.1161/CIRCRESAHA.111.253419. Epub 2011 Dec 29.

13.

Identifying and utilizing the ischemic penumbra.

Fisher M, Bastan B.

Neurology. 2012 Sep 25;79(13 Suppl 1):S79-85. Review.

PMID:
23008418
14.

Cerebral ischemic stroke: is gender important?

Gibson CL.

J Cereb Blood Flow Metab. 2013 Sep;33(9):1355-61. doi: 10.1038/jcbfm.2013.102. Epub 2013 Jun 12. Review.

15.

Treating acute ischemic stroke.

Fisher M, Bastan B.

Curr Opin Drug Discov Devel. 2008 Sep;11(5):626-32. Review.

PMID:
18729014
16.
17.

Is it possible to define salvageable ischemic penumbra using semiquantitative rCBF levels derived from MR perfusion-weighted imaging?

Akazawa K, Yamada K, Matsushima S, Kubota T, Nagakane Y, Kuriyama N, Nakagawa M, Nishimura T.

Neuroradiology. 2008 Nov;50(11):939-45. doi: 10.1007/s00234-008-0427-1. Epub 2008 Jul 24.

PMID:
18651139
18.

Pathophysiology and therapy of experimental stroke.

Hossmann KA.

Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1057-83. Epub 2006 May 19. Review.

PMID:
16710759
19.

[Application of diffusion-weighted and perfusion magnetic resonance imaging in definition of the ischemic penumbra in hyperacute cerebral infarction].

Feng XY, Liang J, Yin XD, Han X, Dong Q, Lü CZ.

Zhonghua Yi Xue Za Zhi. 2003 Jun 10;83(11):952-7. Chinese.

PMID:
12899795
20.

Exploiting the full width of the therapeutic window to salvage the ischemic penumbra: imaging for a cost-effective personalized therapy.

Bastianello S, Del Sole A, Bosone D, Cavallini A, Nappi G.

Funct Neurol. 2006 Oct-Dec;21(4):181-5. No abstract available.

PMID:
17367576

Supplemental Content

Support Center